Expression of the c-Met in advanced epithelial ovarian cancer and its prognostic significance
- 1 July 2005
- journal article
- research article
- Published by Elsevier in International Journal of Gynecological Cancer
- Vol. 15 (4) , 618-623
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Hepatocyte growth factor, transforming growth factor α, and their receptors as combined markers of prognosis in hepatocellular carcinomaMolecular Carcinogenesis, 2003
- Hepatocyte Growth Factor (HGF) Induces Invasion of Endometrial Carcinoma Cell Linesin VitroGynecologic Oncology, 1999
- Hepatocyte Growth Factor Activator: A Possible Regulator of Morphogenesis during Fetal Development of the Rat Gastrointestinal TractBiochemical and Biophysical Research Communications, 1998
- Potential role of hepatocyte growth factor in the maintenance of renal structure: Anti-apoptotic action of HGF on epithelial cellsKidney International, 1998
- Expression of hepatocyte growth factor and its receptor c- met proto-oncogene in hepatocellular carcinomaHepatology, 1997
- The tyrosine kinase receptors Ron and Sea control "scattering" and morphogenesis of liver progenitor cells in vitro.Molecular Biology of the Cell, 1996
- Overexpression of theMET/HGF receptor in ovarian cancerInternational Journal of Cancer, 1994
- Interleukin-6 level in serum and ascites as a prognostic factor in patients with epithelial ovarian cancerCancer, 1994
- Frequent amplification of the c-met gene in scirrhous type stomach cancerBiochemical and Biophysical Research Communications, 1992
- Hepatocyte growth factor is a potent mitogen for cultured rabbit renal tubular epithelial cellsBiochemical and Biophysical Research Communications, 1991